Clincosm LogoSign in Get a demo

neuroendocrine carcinomas

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Neuroendocrine Carcinomas
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

Recruiting
  • Microsatellite High Cancers
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 8, 2022

Neuroendocrine Carcinomas Trial in France (Folfiri-bevacizumab, Folfiri)

Recruiting
  • Neuroendocrine Carcinomas
  • Amiens, France
  • +26 more
Jan 26, 2022

Neuroendocrine Carcinomas Trial in Amsterdam, Groningen, Rotterdam (cisplatinum and everolimus)

Active, not recruiting
  • Neuroendocrine Carcinomas
  • cisplatinum and everolimus
  • Amsterdam, Netherlands
  • +2 more
Apr 19, 2021

Neuroendocrine Carcinomas Trial in Napoli (Temozolomide)

Completed
  • Neuroendocrine Carcinomas
  • Napoli, Campania, Italy
    Istituto Tumori di Napoli - Fondazione G. Pascale
Oct 22, 2020

Neuroendocrine Carcinomas Trial in Taiwan (TLC 388)

Completed
  • Neuroendocrine Carcinomas
  • TLC 388
  • Kaohsiung, Taiwan
  • +6 more
Apr 1, 2019

Neuroendocrine Carcinomas Trial in Italy (bevacizumab + octreotide LAR + capecitabine)

Unknown status
  • Neuroendocrine Carcinomas
  • bevacizumab + octreotide LAR + capecitabine
  • San Giovanni Rotondo, Foggia, Italy
  • +4 more
Sep 15, 2010